Verum Partners LLC

Position in AMGN — Amgen Inc

CIK 1958984 CHARLOTTE, NC

Position in AMGN

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$467,134

+$16,766 QoQ

Shares Held

1,290

+0.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.41%

of 13F equity value

Holder Rank

#2,234

of 3,140 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Verum Partners LLC holds $8,397,946 across 6 Drug Manufacturers - General names. AMGN ranks #5 (5.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,715	$4,455,882
2	JNJ	Johnson & Johnson	6,156	$1,563,439
3	ABBV	AbbVie Inc.	3,851	$969,065
4	MRK	Merck & Co., Inc.	5,758	$739,903
5	AMGN	Amgen Inc This page	1,290	$467,134
6	GILD	Gilead Sciences, Inc.	1,603	$202,523

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$467,134	1,290	+0.8%	Shares	Sole	2026-07-22
2026-03-31	$450,368	1,280	+1.7%	Shares	Sole	2026-04-15
2025-12-31	$411,755	1,258	+1.0%	Shares	Sole	2026-01-14
2025-09-30	$351,621	1,246	-1.1%	Shares	Sole	2025-11-12
2025-06-30	$351,804	1,260	-1.3%	Shares	Sole	2025-07-15
2025-03-31	$397,537	1,276	+0.6%	Shares	Sole	2025-04-11
2024-12-31	$330,752	1,269	-6.6%	Shares	Sole	2025-01-17
2024-09-30	$437,883	1,359	+1.3%	Shares	Sole	2024-10-16
2024-06-30	$418,995	1,341	+2.1%	Shares	Sole	2024-07-15
2024-03-31	$373,596	1,314	+1.4%	Shares	Sole	2024-04-18
2023-12-31	$373,273	1,296	-0.2%	Shares	Sole	2024-01-18
2023-09-30	$349,119	1,299	-38.8%	Shares	Sole	2023-10-10
2023-06-30	$471,126	2,122	—	Shares	Sole	2023-07-24
No filing history on record for this holder in this stock.